Lv1
50 积分 2025-01-06 加入
Comprehensive preclinical pharmacokinetic evaluations of trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, in cynomolgus monkeys
2天前
已完结
ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?
2天前
已完结
A novel FAP-targeting antibody-exatecan conjugate improves immune checkpoint blockade by reversing immunosuppressive microenvironment in pancreatic cancer
1个月前
已完结
950 Preclinical investigation of BDC-4182, a claudin 18.2-targeting ISAC to support clinical development
1个月前
已关闭
Expression, Localization, and Functional Activity of TL1A, a Novel Th1-Polarizing Cytokine in Inflammatory Bowel Disease
1个月前
已完结
CD45-antibody-drug conjugate clears tissue resident myeloid cells from their niches enabling therapeutic adoptive cell transfer
1个月前
已完结
Pharmacokinetics of trastuzumab and its efficacy and safety in HER2-positive cancer patients
3个月前
已完结
HER2-Mediated Internalization of Cytotoxic Agents inERBB2Amplified or Mutant Lung Cancers
4个月前
已完结
Management of HER2 alterations in non-small cell lung cancer – The past, present, and future
4个月前
已完结
OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models
4个月前
已完结